Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids Efficacy in ARDS
NCT06496997Phase 3Completed
- Sponsor
- Fayoum University
- Start
- Aug 2024
- Primary completion
- Apr 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methylprednisolone, dexamethasone, hydrocortisone in acute respiratory distress syndrome (ARDS), sponsored by Fayoum University. Started Aug 2024; status: completed.
02
Drugs
methylprednisolonedexamethasonehydrocortisone
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06496997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06496997.